Sanofi Aventis today (30 June) presented its new R&D model project. The model, which aims to transform R&D and increase innovation, is the first pillar of the group's new stratgey, presented in February by CEO Chris Viehbacher.
The model is centred on the real needs of patients, the development of scientific networks and openess towards outside entities in order to strengthen creativity, and a flexible and entrepreneural approach to research.
Said Dr. Marc Cluzel, Senior VP Research and Development, "We are living through radical times of change for research. Given the increasing complexity of the world of science, we need to change our approach to the patient, make use of novel technologies, and create new concepts. Tomorrow's research will be carried out through networks. WE WILL BE OPEN TO KNOWLEDGE FROM OUTSIDE SOURCES, BECOMING A KEY PARTNER. WE NEED TO RE-INVENT R&D"
No doubt about it. We're playing at the big end of town. The only question now is, how big?
UNI Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)